BURDEN OF OCULAR MANIFESTATIONS IN PATIENTS OF RHEUMATOID ARTHRITIS IN TERTIARY CARE CENTRE OF KUMAON REGION , UTTARAKHAND.

Dr. Smriti Chikara, Dr. Vimlesh Sharma, Dr. Paramjeet Singh, Dr. G. S. Titiyal

Abstract


Rheumatoid arthritis is a chronic systemic inflammatory disease marked by a symmetric, peripheral polyarthritis. It is associated with various extra-articular organ manifestations including subcutaneous nodules, pericarditis, major cutaneous vasculitis, ocular manifestations, hematological abnormalities etc. The well documented ocular manifestations of RA include kerato-conjunctivitis sicca , anterior uveitis, episcleritis, scleritis, scleromalacia perforans, peripheral ulcerative keratitis, corneal filamentary keratitis, retinal vasculitis. The Aim of our study was to identify the rheumatoid arthritis patients with ocular involvement presenting at tertiary care centre of Kumaon region of Uttarakhand. We examined 97 patients with diagnosis of RA. The ocular examintaion included; best corrected visual acuity, slit lamp examination, Schirmer’s test, tear break-up time,indirect ophthalmoscopy and fundus photography in patients with retinal involvement. In this study, the most common manifestation associated with RA was keratoconjunctivitis sicca followed by filamentary keratitis(7.86%) and uveitis (7.86%), scleritis (5%), episcleritis(3%). The least common was panophthalmitis (0.1%). Ocular manifestation among RA patients was found to be very common, i.e. 91.75%  (89 cases, out which 62 were females).

 


Keywords


Rheumatoid Arthritis, Keratoconjunctivitis sicca, retinal vasculitis

Full Text:

PDF

References


E.William St.Clair, Ankoor Shah, Anthony S.Fauci,Carol A. Langford.Harrison’s Rheumatology , 4th edition , chapter6, Rheumatoid arthritis,pg no.89.

Zlatanovic G, Veselinović D, Cekić S, Zivković M, Dorđević-Jocić J, Zlatanović M. Ocular manifestation of rheumatoid arthritis-different forms and frequency. Bosn J Basic Med Sci 2010; 10:324–327.

Felson DT, Anderson JJ, Boers M. American College of Rheumatology. Preliminary defi nition of improvement in rheumatoid arthritis. Arthritis Rheum1995;38:727-735

Turesson C, O’Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over years. Ann. Rheum Dis2003;62:722-727

Sahatçiu-Meka V, Rexhepi S, Manxhuka-Kërliu S, Rexhepi M. Extraaricular manifestation of seronegative and seropositive reumathoid arthritis Bosn. J Basic Med Sci 2010;10(1):27-31

Lilleby V, Gran JT. Systemic rheumatoid arthritis: Tidsskr Nor Laegeforen 1997;117(29):4223-4225

Goronzy JJ, Weyand CM. Developments in the scientifi c understanding of rheumatoid arthritis. Arthritis Res Ther2009;11(5):249

Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS. Infl iximab therapy for the treatment of refractory ocular infl ammatory disease. Arch Ophthalmol2007;125(7):895-900

Sainz de la Maza M., Foster C.S., Jabbur N.S. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmol1994:101(7):1281-1286 -

Fong LP, Sainz de la Maza M, Rice BA, Kupferman AE, Foster CS. Immunopathology of scleritis. Ophthalmol1991;98(4):472-479

Reddy SC, Gupta SD, Jain IS, Deodhar SD. Ocular manifestations of rheumatoid arthritis. Indian J Ophthalmol 1977;25:20-6.

Duke Elder, S. and Leigh A.G. 1955, System of Ophthalmolagy, Part II, 1037. St. Louis, C.G., Mosby Co.

Stanworth, A. 1951, Trans. Ophth. Soe. U.K., 71. 130.

Brown, S.I. and Grayson, M. 1968, Arch. Ophth., 79, 563

Kimura. S.J., Hogan, M.J., Connor, G.R. and Epstia, W.V. 1966, Trans. Amer. Ophth. Soc. 64, 291

Jain, I.S., Gupta, and Sehgal, V N. 1964, Orient. Arch. Ophth. 2, 138.

Chadwic, A.J. and Rosen, E.S. 1968, Amer. J. Ophth. 65, 784

Cimmino MA, Salvarani C, Macchioni P., et al. Extra-articular manifestations in YZ Italian patients with rheumatoid arthritis. Rheumatol Int ;():- []

Kanski JJ. Th e eye in systemic disease. Butterworts London 

Hard, C.R., Snyder, W.B., and Ziff, M. 1970, Amer. J. Med. 48,273.

Diamantis Almaliotis, Marina Zakalka, Antony Gerofotis, Kleopas Chatzicharalampous, Maria Efstathiou, Michael Daniilidis, Vasileios Karampatakis ,Open Journal of Ophthalmology, 2016, 6, 170-175 Ocular Manifestations in Rheumatoid Arthritis .

Patel, S.J. and Lundy, D.C. (2002) Ocular Manifestations of Autoimmune Disease. 66.

Fuerst, D.J., Tanzer, D.J. and Smith, R.E. (1998) Rheumatoid Diseases. International Ophthalmology Clinics, 38, 47- 80.

Shizato, M., Yamamoto, J., Hirata, C.E., Goldberg, C.A., Yoshinari, N.H. and Bonfa, E. (2008) Eye Disease in a Patient with Rheumatoid Arthritis. Vogt-Koyanagi-Harada Syndrome and Rheumatoid Arthritis

del Castillo, B.J.M., Diaz-Valle, D., Pato, E., Abad, L.C. and Alejandre, N. (2008) Articular Diseases and Uveitis. Anales del Sistema Sanitario de Navarra, 31.

McGavin, D.D., Williamson, J., Forrester, J.V., Foulds, W.S., Buchanan, W.W., Dick, W.C., et al. (1976) Episcleritis and Scleritis. A Study of Their Clinical Manifestations and Association with Rheumatoid Arthritis. British Journal of Ophthalmology, 60, 192-226

Harper, S.L. and Foster, C.S. (1998) The Ocular Manifestations of Rheumatoid Disease. International Ophthalmology Clinics, 38, 1-19.

Galor, A. and Thome, J.E. (2007) Scleritis and Peripheral Ulcerative Keratitis. Rheumatic Disease Clinics of North America, 33, 835-854

Kenyon KR: Decision-making in the therapy of external eye disease. Noninfected corneal ulcers. Ophthalmology. 89:44-51 1982 6280121

Staggos, N. (2002) Clinical Ophthalmology, 16, 444-445

Lowder, C.Y. and Char, D. (1984) H. UVEITIS—A Review. Western Journal of Medicine, 140, 421-432.

Marmor, M.F., Kellner, U., Lai, T.Y., Lyons, J.S. and Mieler, W.F. (2011) American Academy of Ophthalmology. Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy. Ophthalmology, 118, 415-422

McGavin DD, Williamson J, Forrester JV, Foulds WS, Buchanan WW, Dick WC, et al. Episcleritis and scleritis. A study of their clinical Charanya, et al.: Ocular Manifestation in Rheumatoid Arthritis International Journal of Scientifc Study | November 2015 | Vol 3 | Issue 8 66 manifestations and association with rheumatoid arthritis. Br J Ophthalmol 1976;60:192-226.

Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-8

Kotaniemi KM, Salomaa PM, Sihto-Kauppi K, Säilä HM, Kauppi MJ. An evaluation of dry eye symptoms and signs in a cohort of children with juvenile idiopathic arthritis. Clin Ophthalmol 2009;3:271-5.

Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol 1976;60:163-91

Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: Clinical features and treatment results. Am J Ophthalmol 2000;130:469-76.

Vignesh AP, Srinivasan R. Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies. Clin Ophthalmol 2015; 9:393–397.

Safaa A. Abouda, Mohamed O. Abd Elkhaleka, Nagla H. Alyb, Enas A. Abd Elaleemc,Ocular involvement and its manifestations in rheumatoid arthritis patients, Delta Journal of Ophthalmology 2017, 18:57–62

Punjabi OS, Adyanthaya RS, Mhatre AD, Jehangir RP. Rheumatoid arthritis is a risk factor for dry eye in the Indian population. Ophthalmic Epidemiol. 2006;13(6):379–384.

Bettero RG, Cebrian RFM, Skare TL. [Prevalence of ocular manifestation in 198 patients with rheumatoid arthritis: a retrospective study]. Arq Bras Oftalmol. 2008;71(3):365–369. Portuguese.

Tong L, Thumboo J, Tan YK, Wong TY, Albani S. The eye: a window of opportunity in rheumatoid arthritis? Nat Rev Rheumatol. 2014;10(9): 552–560.

Villani E, Galimberti D, Viola F, Mapelli C, Papa ND, Ratiglia R. Corneal Involvement in Rheumatoid Arthritis: An In Vivo Confocal Study. Invest Ophthalmol Vis Sci. 2008;49(2):560–564.

Bhadoria DP, Bhadoria P, Sundaram KR, Panda A, Malaviya AN. Ocular manifestations of rheumatoid arthritis. J Indian Med Assoc. 1989; 87(6):134–135.

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies , ammapati Paul Pandian Vignesh renuka srinivasan Department of Ophthalmology, Jawaharlal institute of Postgraduate Medical education and research, Pondicherry, india, Clinical Ophthalmology 2015:9 393–397

van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10

Lemp MA, Hamill JR Jr. Factors affecting tear film breakup in normal eyes. Arch Ophthalmol 1973;89:103

C Charanya, Achanti Swathi, Siddharam Janti, R Pandurangan , Post-graduate, Department of Ophthalmology, Chettinad Hospitals and Research Institute, Chennai, Tamil Nadu, India, Associate Professor, Department of Ophthalmology, Chettinad Hospitals and Research Institute, Chennai, Tamilnadu.

Smith VA, Hoh HB, Easty DL: Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol. 83:1376-1383 1999,10574817

Stern ME, Schaumberg CS, Dana R, et al.: Autoimmunity at the ocular surface: Pathogenesis and regulation. Mucosal Immunol. 3:425-442 2010 ,20485329

Oglesby, R.B., Black. R.L., Sallmann, L. Ven., and Bunin, J.J. 1961, Arch. Ophth. 66, 519

Williamson, J., Paterson, R,W.W., Me Gavin, D.D.M., Jasani, M.K., Boyle, J.A., and Doig. W. M. 1969, Brit. J. Ophth. 53, 363.

Smith, J.L. 1957, Amer. J. Ophth. 43, 575.

Arnett FC, Edworthy SM, Bloch DA. The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324

Goto E, Matsumoto Y, Kamoi M, Endo K, Ishida R, Dogru M. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients. Am J Ophthalmol 2007;144(1):81-85

Barr CC, Davis H, Culberson WW. Rheumatoid scleritis. Ophthalmol 1981;88:1269-1273.


Refbacks

  • There are currently no refbacks.